{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:15:38Z","timestamp":1769728538643,"version":"3.49.0"},"reference-count":83,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,7]],"date-time":"2012-12-07T00:00:00Z","timestamp":1354838400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0051181","type":"journal-article","created":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T04:08:11Z","timestamp":1354939691000},"page":"e51181","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Head-to-Head Comparison of Three Vaccination Strategies Based on DNA and Raw Insect-Derived Recombinant Proteins against Leishmania"],"prefix":"10.1371","volume":"7","author":[{"given":"Felicitat","family":"Todol\u00ed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alhel\u00ed","family":"Rodr\u00edguez-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Carmen","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia D.","family":"Laurenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"G\u00f3mez-Sebasti\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"P\u00e9rez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Escribano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Alberola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,12,7]]},"reference":[{"key":"ref1","unstructured":"WHO (2012) Initiative for Vaccine Research (IVR). Geneva: World Health Orzanization. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/vaccine_research\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/vaccine_research\/en\/<\/ext-link>. Accessed 2012 Nov 8."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"P Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1371\/journal.pntd.0000313","article-title":"Complexities of assessing the disease burden attributable to leishmaniasis","volume":"2","author":"C Bern","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0974-777X.62881","article-title":"Leishmaniasis Vaccine: Where are We Today?","volume":"2","author":"L Kedzierski","year":"2010","journal-title":"J Glob Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"SL Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1017\/S0031182006000837","article-title":"Phenotypical characteristics, biochemical pathways, molecular targets and putative role of nitric oxide-mediated programmed cell death in Leishmania","volume":"132","author":"P Holzmuller","year":"2006","journal-title":"Parasitology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"P Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tvjl.2007.09.014","article-title":"Use of domperidone in the treatment of canine visceral leishmaniasis: a clinical trial","volume":"179","author":"P Gomez-Ochoa","year":"2009","journal-title":"Vet J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","article-title":"The logic of visceral leishmaniasis control","volume":"55","author":"C Dye","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4269\/ajtmh.2012.10-0415","article-title":"The economic value of a visceral leishmaniasis vaccine in Bihar state, India","volume":"86","author":"BY Lee","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN)","volume":"20","author":"GP Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"AP Fernandes","year":"2008","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/j.1469-0691.2011.03610.x","article-title":"Visceral leishmaniasis: immunology and prospects for a vaccine","volume":"17","author":"PM Kaye","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"892817","DOI":"10.1155\/2012\/892817","article-title":"Development of Vaccines against Visceral Leishmaniasis","volume":"2012","author":"KJ Evans","year":"2012","journal-title":"J Trop Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.molmed.2006.03.007","article-title":"Gene-based vaccines: recent technical and clinical advances","volume":"12","author":"JB Ulmer","year":"2006","journal-title":"Trends Mol Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"MJ Ramiro","year":"2003","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1016\/j.vaccine.2007.08.023","article-title":"Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge","volume":"25","author":"A Rodriguez-Cortes","year":"2007","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.it.2003.11.009","article-title":"Jump-starting the immune system: prime-boosting comes of age","volume":"25","author":"DL Woodland","year":"2004","journal-title":"Trends Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1128\/IAI.73.8.5286-5289.2005","article-title":"Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis","volume":"73","author":"B Dondji","year":"2005","journal-title":"Infect Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.vaccine.2007.11.021","article-title":"Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response","volume":"26","author":"I Ramos","year":"2008","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1016\/j.vaccine.2009.08.091","article-title":"Antibiotic resistance free plasmid DNA expressing LACK protein leads towards a protective Th1 response against Leishmania infantum infection","volume":"27","author":"I Ramos","year":"2009","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.vaccine.2005.11.011","article-title":"Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis","volume":"24","author":"S Rafati","year":"2006","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum","volume":"23","author":"S Rafati","year":"2005","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"RN Coler","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-0934(00)00209-3","article-title":"Serodiagnosis of African swine fever using the recombinant protein p30 expressed in insect larvae","volume":"89","author":"MG Barderas","year":"2000","journal-title":"J Virol Methods"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1128\/JCM.00406-06","article-title":"Optimization and validation of recombinant serological tests for African Swine Fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae","volume":"44","author":"DM Perez-Filgueira","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00436-007-0507-x","article-title":"Evaluation of recombinant HP6-Tsag, an 18 kDa Taenia saginata oncospheral adhesion protein, for the diagnosis of cysticercosis","volume":"101","author":"E Ferrer","year":"2007","journal-title":"Parasitol Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jviromet.2008.07.034","article-title":"Development of two Trichoplusia ni larvae-derived ELISAs for the detection of antibodies against replicase and capsid proteins of porcine circovirus type 2 in domestic pigs","volume":"154","author":"E Perez-Martin","year":"2008","journal-title":"J Virol Methods"},{"key":"ref29","first-page":"29","article-title":"DIVA diagnostic of Aujeszky\u2019s disease using an insect-derived virus glycoprotein E. J Virol Methods","volume":"153","author":"S Gomez-Sebastian","year":"2008"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1128\/JCM.00750-09","article-title":"Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae","volume":"47","author":"N Jimenez de Oya","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.vaccine.2010.12.081","article-title":"Alonso-Padilla J, de Oya NJ, Blazquez AB, Escribano-Romero E, Escribano JM, et al. Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease","volume":"29","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.vetpar.2009.05.032","article-title":"Seroreactivity against raw insect-derived recombinant KMPII, TRYP, and LACK Leishmania infantum proteins in infected dogs","volume":"164","author":"F Todoli","year":"2009","journal-title":"Vet Parasitol"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Todoli F, Galindo I, Gomez-Sebastian S, Perez-Filgueira M, Escribano JM, <etal>et al<\/etal>.. (2010) Dynamics and Predictive Potential of Antibodies against Insect-Derived Recombinant <italic>Leishmania infantum<\/italic> Proteins during Chemotherapy of Naturally Infected Dogs. Am J Trop Med Hyg in press.","DOI":"10.4269\/ajtmh.2010.09-0147"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.virol.2007.03.016","article-title":"Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV","volume":"364","author":"DM Perez-Filgueira","year":"2007","journal-title":"Virology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.vaccine.2009.12.061","article-title":"Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae","volume":"28","author":"E Perez-Martin","year":"2010","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pep.2010.06.009","article-title":"Human papillomavirus-like particles vaccine efficiently produced in a non-fermentative system based on insect larva","volume":"74","author":"AF Millan","year":"2010","journal-title":"Protein Expr Purif"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pep.2011.03.007","article-title":"Insect larvae biofactories as a platform for influenza vaccine production","volume":"79","author":"E Gomez-Casado","year":"2011","journal-title":"Protein Expr Purif"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.vaccine.2011.11.005","article-title":"The development and clinical evaluation of second-generation leishmaniasis vaccines","volume":"30","author":"MS Duthie","year":"2012","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0165-2427(00)00221-X","article-title":"Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model","volume":"76","author":"JM Requena","year":"2000","journal-title":"Vet Immunol Immunopathol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00436-002-0738-9","article-title":"Immunological and histopathological studies in a rodent model infected with Leishmania infantum promastigotes or amastigotes","volume":"89","author":"MJ Rica-Capela","year":"2003","journal-title":"Parasitol Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"PC Melby","year":"2001","journal-title":"Infect Immun"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.4049\/jimmunol.176.9.5519","article-title":"Reduced nitric oxide synthase 2 (NOS2) promoter activity in the Syrian hamster renders the animal functionally deficient in NOS2 activity and unable to control an intracellular pathogen","volume":"176","author":"LE Perez","year":"2006","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jim.2011.02.004","article-title":"Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus)","volume":"368","author":"M Zivcec","year":"2011","journal-title":"J Immunol Methods"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/annonc\/mdr154","article-title":"Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome","volume":"23","author":"R Yerushalmi","year":"2012","journal-title":"Ann Oncol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells","volume":"75","author":"RN Coler","year":"2007","journal-title":"Infect Immun"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1016\/j.vaccine.2007.08.001","article-title":"Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant","volume":"25","author":"Y Goto","year":"2007","journal-title":"Vaccine"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4049\/jimmunol.171.3.1133","article-title":"Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice","volume":"171","author":"T Abe","year":"2003","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1128\/JVI.79.5.2847-2858.2005","article-title":"Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus","volume":"79","author":"T Abe","year":"2005","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.4049\/jimmunol.178.4.2361","article-title":"Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN","volume":"178","author":"S Hervas-Stubbs","year":"2007","journal-title":"J Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/156652310791321233","article-title":"Baculovirus as vaccine vectors","volume":"10","author":"S Madhan","year":"2010","journal-title":"Curr Gene Ther"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e24108","DOI":"10.1371\/journal.pone.0024108","article-title":"Baculovirus capsid display potentiates OVA cytotoxic and innate immune responses","volume":"6","author":"P Molinari","year":"2011","journal-title":"PLoS One"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-3024.2009.01142.x","article-title":"Adjuvants for malaria vaccines","volume":"31","author":"RN Coler","year":"2009","journal-title":"Parasite Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s007050170056","article-title":"Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins","volume":"146","author":"MG Barderas","year":"2001","journal-title":"Arch Virol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1286-4579(02)00051-5","article-title":"Characterization of the immune response to Leishmania infantum recombinant antigens","volume":"5","author":"LP de Carvalho","year":"2003","journal-title":"Microbes Infect"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-3083.2005.01581.x","article-title":"Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients","volume":"61","author":"LP Carvalho","year":"2005","journal-title":"Scand J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/IAI.68.2.630-636.2000","article-title":"A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis","volume":"68","author":"I Suffia","year":"2000","journal-title":"Infect Immun"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/IAI.66.5.2135-2142.1998","article-title":"Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis","volume":"66","author":"PC Melby","year":"1998","journal-title":"Infect Immun"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.micinf.2005.03.010","article-title":"Plasmid DNA vaccination","volume":"7","author":"K Huygen","year":"2005","journal-title":"Microbes Infect"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vaccine.2008.10.013","article-title":"DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB\/c mice","volume":"27","author":"SB Ahmed","year":"2009","journal-title":"Vaccine"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","article-title":"Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis","volume":"174","author":"R Basu","year":"2005","journal-title":"J Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1073\/pnas.0712153105","article-title":"Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model","volume":"105","author":"R Gomes","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by L-arginine metabolism","volume":"5","author":"V Bronte","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0264-410X(00)00398-4","article-title":"Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters","volume":"19","author":"K Fragaki","year":"2001","journal-title":"Vaccine"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.rvsc.2007.04.020","article-title":"Histopathological and immunohistochemical investigations of the hepatic compartment associated with parasitism and serum biochemical changes in canine visceral leishmaniasis","volume":"84","author":"RC Giunchetti","year":"2008","journal-title":"Res Vet Sci"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0264-410X(01)00427-3","article-title":"A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36\/LACK antigen protects BALB\/c mice from cutaneous leishmaniasis","volume":"20","author":"RM Gonzalo","year":"2002","journal-title":"Vaccine"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1128\/IAI.72.8.4924-4928.2004","article-title":"DNA-Salmonella enterica serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice","volume":"72","author":"UG Lange","year":"2004","journal-title":"Infect Immun"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1086\/430348","article-title":"A heterologous prime-boost vaccination regimen using ORFF DNA and recombinant ORFF protein confers protective immunity against experimental visceral leishmaniasis","volume":"191","author":"P Tewary","year":"2005","journal-title":"J Infect Dis"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1016\/j.vaccine.2006.01.030","article-title":"Comparison of potential protection induced by three vaccination strategies (DNA\/DNA, Protein\/Protein and DNA\/Protein) against Leishmania major infection using Signal Peptidase type I in BALB\/c mice","volume":"24","author":"S Rafati","year":"2006","journal-title":"Vaccine"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"e14644","DOI":"10.1371\/journal.pone.0014644","article-title":"Potency, efficacy and durability of DNA\/DNA, DNA\/protein and protein\/protein based vaccination using gp63 against Leishmania donovani in BALB\/c mice","volume":"6","author":"S Mazumder","year":"2011","journal-title":"PLoS One"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/bmj.39048.407928.BE","article-title":"Comparison of treatment effects between animal experiments and clinical trials: systematic review","volume":"334","author":"P Perel","year":"2007","journal-title":"British Medical Journal"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/tx800204g","article-title":"The Muddle of Models: What You Don\u2019t Know Can Hurt You","volume":"21","author":"DG Robertson","year":"2008","journal-title":"Chemical Research in Toxicology"},{"key":"ref72","doi-asserted-by":"crossref","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"L Kedzierski","year":"2006","journal-title":"Parasitology"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","article-title":"The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response","volume":"166","author":"PC Melby","year":"2001","journal-title":"J Immunol"},{"key":"ref74","unstructured":"Russell W, Burch R (1959) The Principles of Humane Experimental Technique. London: Methuen."},{"key":"ref75","first-page":"50","article-title":"The 4th R of research","volume":"34","author":"RE Banks","year":"1995","journal-title":"Contemp Top Lab Anim Sci"},{"key":"ref76","unstructured":"WHO (1997) Guidelines for the Evaluation of <italic>Plasmodium falciparum<\/italic> Vaccines in Populations Exposed to Natural Infections. Geneva: World Health Organisation."},{"key":"ref77","first-page":"1","article-title":"Vaccines for canine leishmaniasis","volume":"69)","author":"CB Palatnik-de-Sousa","year":"2012","journal-title":"Front Immunol 3 (Article"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0020-7519(97)00169-0","article-title":"The immune response to Leishmania: mechanisms of parasite control and evasion","volume":"28","author":"C Bogdan","year":"1998","journal-title":"International Journal for Parasitology"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-4017(99)00084-9","article-title":"Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate","volume":"84","author":"C Riera","year":"1999","journal-title":"Vet Parasitol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1128\/AAC.48.2.641-643.2004","article-title":"Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis","volume":"48","author":"J Alberola","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vetpar.2006.01.011","article-title":"Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis","volume":"137","author":"O Francino","year":"2006","journal-title":"Vet Parasitol"},{"key":"ref83","first-page":"289","article-title":"\u201cControlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B (Methodological)","volume":"57","author":"Y Benjamini","year":"1995"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0051181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T08:55:01Z","timestamp":1595062501000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0051181"}},"subtitle":[],"editor":[{"given":"Anil Kumar","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,7]]},"references-count":83,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0051181","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,7]]}}}